tv005
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT02317900)
Timeline
Indications
Studied for
Mechanism of action
- Dengue virusImmunity, active
Dengue virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tv005
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05229354 | Phase 2 | Dec 11, 2021 | International Center for Diarrheal Disease Research, University of Vermont |
| NCT02678455 | Phase 2 | Mar 1, 2016 | International Center for Diarrheal Disease Research, Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), University of Vermont |
| NCT02317900 | Phase 1 | Dec 1, 2014 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| International Center for Diarrheal Disease Research | Academic/Hospital | 2 | 0 | 1 | 2016 |
| Johns Hopkins University | Academic/Hospital | 2 | 0 | 2 | 2014 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 2 | 2014 |
| University of Vermont | Academic/Hospital | 2 | 1 | 1 | 2016 |
4 organizations
Page 1 / 1